Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Xie, Jinbing; Shen, Zheyu; Anraku, Yasutaka; Kataoka, Kazunori; Chen, Xiaoyuan

doi:10.1016/j.biomaterials.2019.119491

Cited by 604Barrier Structure and Function StudiesNanoparticle-Based Drug DeliveryDrug Transport and Resistance Mechanisms

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Open access

Xie, Jinbing, Shen, Zheyu, Anraku, Yasutaka, Kataoka, Kazunori, Chen, Xiaoyuan·2019·Biomaterials

DOI 10.1016/j.biomaterials.2019.119491PMC PMC6915305

Open this paper in CoChat — free account

Abstract

Increasing attention has been paid to the diseases of central nervous system (CNS). The penetration efficiency of most CNS drugs into the brain parenchyma is rather limited due to the existence of blood-brain barrier (BBB). Thus, BBB crossing for drug delivery to CNS remains a significant challenge in the development of neurological therapeutics. Because of the advantageous properties (e.g., relatively high drug loading content, controllable drug release, excellent passive and active targeting, good stability, biodegradability, biocompatibility, and low toxicity), nanomaterials with BBB-crossability have been widely developed for the treatment of CNS diseases. This review summarizes the current understanding of the physiological structure of BBB, and provides various nanomaterial-based BBB-crossing strategies for brain delivery of theranostic agents, including intranasal delivery, temporary disruption of BBB, local delivery, cell penetrating peptide (CPP) mediated BBB-crossing, receptor mediated BBB-crossing, shuttle peptide mediated BBB-crossing, and cells mediated BBB-crossing. Clinicians, biologists, material scientists and chemists are expected to be interested in this review.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2019.119491

Cites

234 of 234 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Endothelial cells, astroglia, pericytes, and junctional complexes including tight junctions and adherens junctions basically compose the blood-brain barrier.
“From the physiological point of view, endothelial cells, astroglia, pericytes, and junctional complexes including tight junctions and adherens junctions compose the BBB basically.36–39”
From The blood–brain barrier: Structure, regulation and drug delivery (2023) · cites this paper as [39]
The “BBB and CNS diseases > BBB” section describes endothelial cells and tight junctions in the inner layer and astrocytes in the outer layer. It does not identify pericytes or adherens junctions as BBB components. No page number is provided in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED ARTICLE: Pericyte loss influences Alzheimer-like neurodegeneration in mice
Sagare, A. P., Bell, R. D., Zhao, Z., Ma, Q., Winkler, E. A., Ramanathan, A., & Zlokovic, B. V. (2013) · Nature Communications · doi:10.1038/ncomms3932 · Cited by 589 · see citing works
Retracted
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella‐Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,703 · see citing works
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,422 · see citing works
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670 · see citing works
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,597 · see citing works
Convection-enhanced delivery of macromolecules in the brain.
Bobo, R. H., Laske, D. W., Akbaşak, A., Morrison, P. F., Dedrick, R. L., & Oldfield, E. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2076 · Cited by 1,414 · see citing works
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060 · see citing works
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L.-D., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 1,048 · see citing works
Cloning by functional expression of a member of the glutamate receptor family
Hollmann, M., O'Shea-Greenfield, A., Rogers, S. W., & Heinemann, S. F. (1989) · Nature · doi:10.1038/342643a0 · Cited by 1,016 · see citing works
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,005 · see citing works
Mechanisms of Cellular Uptake of Cell-Penetrating Peptides
Madani, F., Lindberg, S., Langel, Ü., Futaki, S., & Gräslund, A. (2011) · Journal of Biophysics · doi:10.1155/2011/414729 · Cited by 986 · see citing works
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S., Chiappini, C., Liu, X., & Mauro Ferrari, B. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 966 · see citing works
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954 · see citing works
The Shape Effect of Mesoporous Silica Nanoparticles on Biodistribution, Clearance, and Biocompatibility in Vivo
Huang, X., Li, L., Liu, T., Hao, N., Liu, H., Chen, D., & Tang, F. (2011) · ACS Nano · doi:10.1021/nn200365a · Cited by 927 · see citing works
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zloković, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 921 · see citing works
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Uchida, Y., Ohtsuki, S., Katsukura, Y., Ikeda, C., Suzuki, T., Kamiie, J., & Terasaki, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07208.x · Cited by 881 · see citing works
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 859 · see citing works
Cell-penetrating peptides: classes, origin, and current landscape
Milletti, F. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.002 · Cited by 811 · see citing works
Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases
Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 804 · see citing works
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Yu, Y. J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y., Atwal, J., Elliott, J. M., Prabhu, S., Watts, R. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002230 · Cited by 794 · see citing works
Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability
Lockman, P. R., Koziara, J. M., Mumper, R. J., & Allen, D. D. (2004) · Journal of drug targeting · doi:10.1080/10611860400015936 · Cited by 742 · see citing works
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium
Kolhar, P., Anselmo, A. C., Gupta, V., Pant, K., Prabhakarpandian, B., Ruoslahti, E. I., & Mitragotri, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308345110 · Cited by 648 · see citing works
Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors
Shen, Z., Liu, T., Li, Y., Lau, J., Yáng, Z., Fan, W., Zhou, Z., Shi, C., Ke, C., Bregadze, V. I., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06201 · Cited by 636 · see citing works
Self-citation
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., Rueger, P., Stracke, J. O., Lau, W., Tissot, A. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.061 · Cited by 622 · see citing works
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Tang, W., Fan, W., Lau, J., Deng, L., Shen, Z., & Chen, X. S. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00805a · Cited by 606 · see citing works
Self-citation
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)
Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591 · see citing works
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572 · see citing works
Polymeric nanoparticles for drug delivery to the central nervous system
Patel, T., Zhou, J., Piepmeier, J. M., & Saltzman, W. M. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.006 · Cited by 569 · see citing works
Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in <scp>A</scp> lzheimer's Disease
Sengillo, J. D., Winkler, E. A., Walker, C. T., Sullivan, J. S., Johnson, M., & Zlokovic, B. V. (2013) · Brain Pathology · doi:10.1111/bpa.12004 · Cited by 553 · see citing works
RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519 · see citing works
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
Kunwar, S., Chang, S. M., Westphal, M., Vogelbaum, M. A., Sampson, J. H., Barnett, G. H., Shaffrey, M. E., Ram, Z., Piepmeier, J., Prados, M. D., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop054 · Cited by 484 · see citing works
Delivery of peptides and proteins through the blood–brain barrier
Bickel, U., Yoshikawa, T., & Pardridge, W. M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00139-3 · Cited by 482 · see citing works
Direct nose to brain drug delivery <i>via</i> integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting
Pardeshi, C. V., & Belgamwar, V. S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.790887 · Cited by 482 · cited 2× · see citing works
“However, the existence of significant differences in drug delivery efficiency between various nasal routes indicates that further studies of more effective intranasal delivery strategies are still required [111,118,119].”
Background
Blood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke
Khatri, R., McKinney, A. M., Swenson, B., & Janardhan, V. (2012) · Neurology · doi:10.1212/wnl.0b013e3182697e70 · Cited by 478 · see citing works
Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation
Abbott, N. J. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1374-y · Cited by 471 · see citing works
Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles
Kreuter, J., Ramge, P., Petrov, V. E., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R. N., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469 · see citing works
Current concepts and management of glioblastoma
Preusser, M., de Ribaupierre, S., Wöehrer, A., Erridge, S., Hegi, M. E., Weller, M., & Stupp, R. (2011) · Annals of Neurology · doi:10.1002/ana.22425 · Cited by 457 · see citing works
Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease
Cabezas, R., Ávila, M. F., González, J., El-Bachá, R. D. S., Báez-Jurado, E., García‐Segura, L. M., Jurado-Coronel, J. C., Capani, F., Cardona‐Gómez, G. P., & Barreto, G. E. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00211 · Cited by 453 · see citing works
Kojic acid applications in cosmetic and pharmaceutical preparations
Saeedi, M., Eslamifar, M., & Khezri, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.006 · Cited by 423 · see citing works
Specific role of tight junction proteins claudin-5, occludin and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult
Jiao, H., Wang, Z., Liu, Y., Wang, P., & Xue, Y. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9496-4 · Cited by 411 · see citing works
Striatal Blood–Brain Barrier Permeability in Parkinson'S Disease
Gray, M. T., & Woulfe, J. M. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.32 · Cited by 409 · see citing works
Human Blood—Brain Barrier Insulin Receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07167.x · Cited by 399 · see citing works
AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study
Immonen, A., Vapalahti, M. P., Tyynelä, K., Hurskainen, H., Sandmair, A.-M., Vanninen, R. L., Langford, G. A., Murray, N., & Ylä‐Herttuala, S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.002 · Cited by 390 · see citing works
A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells
Cecchelli, R., Aday, S., Sevin, E., Praça, C., Culot, M., Dehouck, L., Coisne, C., Engelhardt, B., Dehouck, M., & Ferreira, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099733 · Cited by 361 · see citing works
Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations
Hu, K., Li, J., Shen, Y., Lü, W., Gao, X., Zhang, Q., & Jiang, X. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.016 · Cited by 354 · see citing works
Quantitative analysis of drug delivery to the brain via nasal route
Kozlovskaya, L., Abou-Kaoud, M., & Stepensky, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.053 · Cited by 345 · see citing works
Receptor-Mediated Delivery of Magnetic Nanoparticles across the Blood–Brain Barrier
Qiao, R., Jia, Q., Hüwel, S., Xia, R., Liu, T., Gao, F., Galla, H., & Gao, M. (2012) · ACS Nano · doi:10.1021/nn300240p · Cited by 329 · see citing works
Cell-mediated drug delivery
Batrakova, E. V., Gendelman, H. E., & Kabanov, A. V. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.559457 · Cited by 324 · see citing works
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
van Assema, D. M. E., Lubberink, M., Bauer, M., van der Flier, W. M., Schuit, R. C., Windhorst, A. D., Comans, E. F. I., Hoetjes, N. J., Tolboom, N., Langer, O., et al. (2012) · Brain · doi:10.1093/brain/awr298 · Cited by 318 · see citing works
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis
Yeste, A., Nadeau, M., Burns, E. J., Weiner, H. L., & Quintana, F. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120611109 · Cited by 303 · see citing works
The Effect of Nanoparticle Size on the Ability to Cross the Blood–Brain Barrier: An In Vivo Study
Betzer, O., Shilo, M., Opochinsky, R., Barnoy, E. A., Motiei, M., Okun, E., Yadid, G., & Popovtzer, R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0022 · Cited by 302 · see citing works
Thymidine Kinase Gene Therapy for Human Malignant Glioma, Using Replication-Deficient Retroviruses or Adenoviruses
Sandmair, A.-M., Loimas, S., Puranen, P., Immonen, A., Kossila, M., Puranen, M. I., Hurskainen, H., Tyynelä, K., Turunen, M., Vanninen, R., et al. (2000) · Human Gene Therapy · doi:10.1089/104303400750035726 · Cited by 300 · see citing works
Diffusion of Macromolecules in the Brain: Implications for Drug Delivery
Wolak, D. J., & Thorne, R. G. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300495e · Cited by 299 · see citing works
Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T 1 -Weighted Magnetic Resonance Imaging and Chemotherapy
Shen, Z., Chen, T., Ma, X., Ren, W., Zhou, Z., Zhu, G., Zhang, A., Liu, Y., Song, J., Li, Z., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b04924 · Cited by 298 · see citing works
Self-citation
Targeting the brain with PEG–PLGA nanoparticles modified with phage-displayed peptides
Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., Chen, J., Pang, Z., Wang, Y., Jiang, X., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.031 · Cited by 295 · see citing works
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
Anraku, Y., Kuwahara, H., Fukusato, Y., Mizoguchi, A., Ishii, T., Nitta, K., Matsumoto, Y., Toh, K., Miyata, K., Uchida, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00952-3 · Cited by 295 · see citing works
Self-citation
Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles
Gao, H., Qian, J., Cao, S., Yang, Z. H., Pang, Z., Pan, S., Fan, L., Xi, Z., Jiang, X., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.058 · Cited by 280 · see citing works
Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core
Clark, A. J., & Davis, M. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517048112 · Cited by 279 · see citing works
Synthesis and Cellular Uptake of Folic Acid-Conjugated Cellulose Nanocrystals for Cancer Targeting
Dong, S., Cho, H. J., Lee, Y. W., & Roman, M. (2014) · Biomacromolecules · doi:10.1021/bm401593n · Cited by 276 · see citing works
Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration
Nance, E. A., Zhang, C., Shih, T.-Y., Xu, Q., Schuster, B. S., & Hanes, J. S. (2014) · ACS Nano · doi:10.1021/nn504210g · Cited by 266 · see citing works
Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood–brain barrier
Wong, D. K., Dorovini‐Zis, K., & Vincent, S. R. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.008 · Cited by 264 · see citing works
Anatomical and Histological Factors Affecting Intranasal Drug and Vaccine Delivery
Gizurarson, S. S. (2012) · Current Drug Delivery · doi:10.2174/156720112803529828 · Cited by 264 · see citing works
Stroke, Vascular Dementia, and Alzheimer’s Disease: Molecular Links
Vijayan, M., & Reddy, P. H. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160527 · Cited by 264 · see citing works
Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice
Zhang, C., Xu, W., Zheng, X., Shao, X., Liu, Q., Zhang, Q., & Qian, Y. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.063 · Cited by 262 · see citing works
Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood–tumor and blood–brain barriers improve outcomes in a rat glioma model
Aryal, M., Vykhodtseva, N. I., Zhang, Y., Park, J., & McDannold, N. J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.007 · Cited by 261 · see citing works
Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)
Ulbrich, K., Knobloch, T., & Kreuter, J. (2011) · Journal of Drug Targeting · doi:10.3109/10611861003734001 · Cited by 259 · see citing works
Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood-Brain Barrier Integrity by a Gap Junction-Dependent Mechanism
Eugenín, E. A., Clements, J. E., Zink, M. C., & Berman, J. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1460-11.2011 · Cited by 253 · see citing works
A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery
Chai, Z., Hu, X., Wei, X., Zhan, C., Lu, L., Jiang, K., Su, B., Ruan, H., Ran, D., Fang, R. H., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.027 · Cited by 253 · see citing works
Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration
Yokel, R. A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-102-309 · Cited by 246 · see citing works
The Role of Drug Transporters at the Blood-Brain Barrier
de Boer, A. G., van der Sandt, I. C. J., & Gaillard, P. J. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140204 · Cited by 239 · see citing works
Poly(ethylene glycol)-Coated Hexadecylcyanoacrylate Nanospheres Display a Combined Effect for Brain Tumor Targeting
Brigger, I., Morizet, J., Aubert, G., Chacun, H., Terrier‐Lacombe, M., Couvreur, P., & Vassal, G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039669 · Cited by 234 · see citing works
The function of scavenger receptorsexpressed by macrophages and their rolein the regulation of inflammation
Peiser, L., & Gordon, S. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01362-9 · Cited by 224 · see citing works
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Hultqvist, G., Syvänen, S., Fang, X. T., Lannfelt, L., & Sehlin, D. (2017) · Theranostics · doi:10.7150/thno.17155 · Cited by 224 · see citing works
Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.
Faucheux, B. A., Nillesse, N., Damier, P., Spik, G., Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J., & Agid, Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9603 · Cited by 218 · see citing works
Chemotherapeutic Drugs Released from Polymers: Distribution of 1,3-bis(2-chloroethyl)-l-nitrosourea in the Rat Brain
Fung, L. K., Shin, M., Tyler, B., Brem, H., & Saltzman, W. M. (1996) · Pharmaceutical Research · doi:10.1023/a:1016083113123 · Cited by 213 · see citing works
Surface Characteristics of Nanoparticles Determine Their Intracellular Fate in and Processing by Human Blood–Brain Barrier Endothelial Cells In Vitro
Georgieva, J. V., Kalicharan, D., Couraud, P., Romero, I. A., Weksler, B. B., Hoekstra, D., & Zuhorn, I. S. (2010) · Molecular Therapy · doi:10.1038/mt.2010.236 · Cited by 211 · see citing works
Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery
Vazana, U., Veksler, R., Pell, G. S., Prager, O., Fassler, M., Chassidim, Y., Roth, Y., Shahar, H., Zangen, A., Raccah, R., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0587-16.2016 · Cited by 205 · see citing works
Microemulsion-Based Soft Bacteria-Driven Microswimmers for Active Cargo Delivery
Singh, A. V., Hosseinidoust, Z., Park, B.-W., Yaşa, Ö., & Sitti, M. (2017) · ACS Nano · doi:10.1021/acsnano.7b02082 · Cited by 199 · see citing works
Polymeric implants for cancer chemotherapy
Fung, L. K., & Saltzman, W. M. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00036-7 · Cited by 198 · see citing works
Nanotechnology—novel therapeutics for CNS disorders
Srikanth, M., & Kessler, J. A. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.76 · Cited by 198 · see citing works
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
Sampson, J. H., Akabani, G., Archer, G. E., Berger, M. S., Coleman, R. E., Friedman, A. H., Friedman, H. S., Greer, K. L., Herndon, J. E., Kunwar, S., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-012 · Cited by 196 · see citing works
Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications
Shilo, M., Motiei, M., Hana, P., & Popovtzer, R. (2013) · Nanoscale · doi:10.1039/c3nr04878k · Cited by 195 · see citing works
Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation
Gaillard, P. J., Appeldoorn, C. C. M., Rip, J., Dorland, R., van der Pol, S. M. A., Kooij, G., de Vries, H. E., & Reijerkerk, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.022 · Cited by 191 · see citing works
Phase I Study of GRN1005 in Recurrent Malignant Glioma
Drappatz, J., Brenner, A., Wong, E. T., Eichler, A., Schiff, D., Groves, M. D., Mikkelsen, T., Rosenfeld, S., Sarantopoulos, J., Meyers, C. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2481 · Cited by 190 · see citing works
Three-Dimensional Blood-Brain Barrier Model for in vitro Studies of Neurovascular Pathology
Cho, H., Seo, J. H., Wong, K. H. K., Terasaki, Y., Park, J., Bong, K., Arai, K., Lo, E. H., & Irimia, D. (2015) · Scientific Reports · doi:10.1038/srep15222 · Cited by 190 · see citing works
Targeted Delivery of Functionalized Upconversion Nanoparticles for Externally Triggered Photothermal/Photodynamic Therapies of Brain Glioblastoma
Tsai, Y.-C., Vijayaraghavan, P., Chiang, W., Chen, H., Liu, T., Shen, M., Omoto, A., Kamimura, M., Soga, K., & Chiu, H. (2018) · Theranostics · doi:10.7150/thno.22482 · Cited by 183 · see citing works
A D ‐Peptide Ligand of Nicotine Acetylcholine Receptors for Brain‐Targeted Drug Delivery
Wei, X., Zhan, C., Shen, Q., Fu, W., Xie, C., Gao, J., Peng, C., Zheng, P., & Lu, W. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201411226 · Cited by 181 · see citing works
Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors
Kurzrock, R., Gabrail, N., Chandhasin, C., Moulder, S. L., Smith, C. S., Brenner, A. J., Sankhala, K. K., Mita, A. C., Elian, K., Bouchard, D., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0566 · Cited by 181 · see citing works
Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs
Sharma, M., Sharma, R., & Jain, D. K. (2016) · Scientifica · doi:10.1155/2016/8525679 · Cited by 180 · see citing works
Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson's disease therapy
Zhang, N., Yan, F., Liang, X., Wu, M., Shen, Y., Chen, M., Xu, Y., Zou, G., Jiang, P., Tang, C., et al. (2018) · Theranostics · doi:10.7150/thno.23734 · Cited by 180 · see citing works
A leptin derived 30-amino-acid peptide modified pegylated poly-l-lysine dendrigraft for brain targeted gene delivery
Liu, Y., Li, J., Shao, K., Huang, R., Ye, L., Lou, J., & Jiang, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.011 · Cited by 172 · see citing works
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma
Boockvar, J. A., Tsiouris, A. J., Hofstetter, C. P., Kovanlikaya, I., Fralin, S. R., Kesavabhotla, K., Seedial, S. M., Pannullo, S. C., Schwartz, T. H., Stieg, P. E., et al. (2010) · Journal of neurosurgery · doi:10.3171/2010.9.jns101223 · Cited by 170 · see citing works
Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the rat
Moos, T., & Morgan, E. H. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00541.x · Cited by 169 · see citing works
Stem Cell-Based Human Blood–Brain Barrier Models for Drug Discovery and Delivery
Aday, S., Cecchelli, R., Hallier-Vanuxeem, D., Dehouck, M. P., & Ferreira, L. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.01.001 · Cited by 169 · see citing works
The blood–brain-barrier in multiple sclerosis: Functional roles and therapeutic targeting
Correale, J., & Villa, A. (2007) · Autoimmunity · doi:10.1080/08916930601183522 · Cited by 167 · see citing works
Pharmacokinetics and brain uptake of lactoferrin in rats
Ji, B., Maeda, J., Higuchi, M., Inoue, K., Akita, H., Harashima, H., & Suhara, T. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.085 · Cited by 166 · see citing works
Overcoming the Blood–Brain Barrier for Delivering Drugs into the Brain by Using Adenosine Receptor Nanoagonist
Gao, X., Qian, J., Zheng, S., Changyi, Y., Zhang, J., Ju, S., Zhu, J., & Li, C. (2014) · ACS Nano · doi:10.1021/nn5003375 · Cited by 165 · see citing works
Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System
Gao, H., Pang, Z., & Jiang, X. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1122-4 · Cited by 164 · see citing works
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma
Staquicini, F. I., Ozawa, M. G., Moya, C. A., Driessen, W. H. P., Barbu, E. M., Nishimori, H., Soghomonyan, S., Flores, L. G., Liang, X., Paolillo, V., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci44798 · Cited by 163 · see citing works
Receptor-Mediated Endocytosis and Brain Delivery of Therapeutic Biologics
Xiao, G., & Gan, L.-S. L. (2013) · International Journal of Cell Biology · doi:10.1155/2013/703545 · Cited by 163 · see citing works
Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion
Gosk, S., Vermehren, C., Storm, G., & Moos, T. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000135592.28823.47 · Cited by 162 · see citing works
Synergistic Dual-Ligand Doxorubicin Liposomes Improve Targeting and Therapeutic Efficacy of Brain Glioma in Animals
Zong, T., Mei, L., Gao, H., Cai, W., Zhu, P., Shi, K., Chen, J., Wang, Y., Gao, F., & He, Q. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500057n · Cited by 160 · see citing works
Regulation of cerebral vasculature in normal and ischemic brain
Kulik, T. B., Kusano, Y., Aronhime, S., Sandler, A. L., & Winn, H. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.04.017 · Cited by 159 · see citing works
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease
Pisani, V., Stefani, A., Pierantozzi, M., Natoli, S., Stanzione, P., Franciotta, D., & Pisani, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-188 · Cited by 158 · see citing works
Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes In Vitro
Gromnicova, R., Davies, H. A., Sreekanthreddy, P., Romero, I. A., Lund, T., Roitt, I. M., Phillips, J. B., & Male, D. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081043 · Cited by 157 · see citing works
Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles
Johnsen, K. B., Bak, M., Kempen, P. J., Melander, F., Burkhart, A., Thomsen, M. S., Nielsen, M. S., Moos, T., & Andresen, T. L. (2018) · Theranostics · doi:10.7150/thno.25228 · Cited by 157 · see citing works
Theranostic USPIO‐Loaded Microbubbles for Mediating and Monitoring Blood‐Brain Barrier Permeation
Lammers, T., Koczera, P., Fokong, S., Gremse, F., Ehling, J., Vogt, M., Pich, A., Storm, G., van Zandvoort, M., & Kiessling, F. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201401199 · Cited by 156 · see citing works
Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics
Bose, R. J., Paulmurugan, R., Moon, J. J., Lee, S., & Park, H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.02.001 · Cited by 154 · see citing works
Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications
Ahire, E. D., Thakkar, S., Darshanwad, M., & Misra, M. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.07.011 · Cited by 153 · see citing works
Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody
Pardridge, W. M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.952627 · Cited by 152 · see citing works
Micelle‐Based Brain‐Targeted Drug Delivery Enabled by a Nicotine Acetylcholine Receptor Ligand
Zhan, C., Li, B., Hu, L., Wei, X., Feng, L., Fu, W., & Lu, W. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100875 · Cited by 152 · see citing works
Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats
Rip, J., Chen, L., Hartman, R., van den Heuvel, A., Reijerkerk, A., van Kregten, J., van der Boom, B. G., Appeldoorn, C. C. M., de Boer, M., Maussang, D., et al. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.888070 · Cited by 149 · see citing works
Nanotechnology Solutions for Alzheimer's Disease: Advances in Research Tools, Diagnostic Methods and Therapeutic Agents
Nazem, A., & Mansoori, G. A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13210 · Cited by 148 · see citing works
In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer
Alibolandi, M., Ramezani, M., Abnous, K., Sadeghi, F., Atyabi, F., Asouri, M., Ahmadi, A. A., & Hadizadeh, F. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.026 · Cited by 147 · see citing works
Blood–brain barrier disruption induces <i>in vivo</i> degeneration of nigral dopaminergic neurons
Rite, I., Machado, A., Cano, J., & Venero, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04567.x · Cited by 147 · see citing works
Angiopep-Conjugated Nanoparticles for Targeted Long-Term Gene Therapy of Parkinson’s Disease
Huang, R., Ma, H., Guo, Y., Liu, S., Kuang, Y., Shao, K., Li, J., Liu, Y., Han, L., Huang, S., et al. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1005-8 · Cited by 146 · see citing works
Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals
Qin, Y., Chen, H., Zhang, Q., Wang, X., Yuan, W., Kuai, R., Tang, J., Zhang, L., Zhang, Z., Zhang, Q., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.09.008 · Cited by 144 · see citing works
Endothelial Vesicles in the Blood–Brain Barrier: Are They Related to Permeability?
Stewart, P. A. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007026504843 · Cited by 142 · see citing works
Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease
Hirano, S., Asanuma, K., Ma, Y., Tang, C., Feigin, A., DHAWAN, V. M., Carbon, M., & Eidelberg, D. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0582-08.2008 · Cited by 142 · see citing works
Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy
Desai Bradaric, B., Patel, A., Schneider, J. A., Carvey, P. M., & Hendey, B. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0684-8 · Cited by 139 · see citing works
Influence of surface charge and inner composition of porous nanoparticles to cross blood–brain barrier in vitro
Jallouli, Y., Paillard, A., Chang, J., Sevin, E., & Betbeder, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.023 · Cited by 139 · see citing works
ABC efflux transporters in brain vasculature of Alzheimer's subjects
Wijesuriya, H. C., Bullock, J. Y., Faull, R. L. M., Hladky, S. B., & Barrand, M. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.034 · Cited by 135 · see citing works
Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors
Iv, M., Telischak, N., Feng, D., Holdsworth, S. J., Yeom, K. W., & Daldrup-Link, H. E. (2015) · Nanomedicine · doi:10.2217/nnm.14.203 · Cited by 134 · see citing works
Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles
Wei, L., Guo, X., Yang, T., Yu, M., Chen, D., & Wang, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.127 · Cited by 133 · see citing works
Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for Aβ accumulation in AD brain
Owen, J. B., Rukhsana Sultana, A., Aluise, C. D., Erickson, M. A., Price, T. O., Bu, G., Banks, W. A., & Butterfield, D. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.013 · Cited by 130 · see citing works
Three-dimensional transcranial microbubble imaging for guiding volumetric ultrasound-mediated blood-brain barrier opening
Jones, R. M., Deng, L., Leung, K., McMahon, D., O’Reilly, M. A., & Hynynen, K. (2018) · Theranostics · doi:10.7150/thno.24911 · Cited by 128 · see citing works
Efficacy of interleukin-13 receptor–targeted liposomal doxorubicin in the intracranial brain tumor model
Madhankumar, A. B., Slagle‐Webb, B., Wang, X., Yang, Q. X., Antonetti, D. A., Miller, P. A., Sheehan, J. M., & Connor, J. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0853 · Cited by 124 · see citing works
Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122 · see citing works
Imaging Approach to Mechanistic Study of Nanoparticle Interactions with the Blood–Brain Barrier
Bramini, M., Dong, Y., Hallerbach, A., Raghnaill, M. N., Salvati, A. L., Åberg, C., & Dawson, K. A. (2014) · ACS Nano · doi:10.1021/nn5018523 · Cited by 121 · see citing works
Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases
Leveugle, B., Faucheux, B. A., Bouras, C., Nillesse, N., Spik, G., Hirsch, É. C., Agid, Y., & Hof, P. R. (1996) · Acta Neuropathologica · doi:10.1007/s004010050468 · Cited by 120 · see citing works
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian
Barcia, C., Bautista‐Hernández, V., Sánchez-Bahíllo, A., Fernández‐Villalba, E., Faucheux, B. A., Poza, M., Barreiro, A. F., Hirsch, É. C., & Herrero, M. T. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0256-2 · Cited by 119 · see citing works
dNP2 is a blood–brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis
Lim, S., Kim, W., Kim, Y.-H., Lee, S., Koo, J., Lee, J.-A., Yoon, H., Kim, D.-H., Park, H.-J., Kim, H.-M., et al. (2015) · Nature Communications · doi:10.1038/ncomms9244 · Cited by 119 · see citing works
A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
Reddy, P. H., Tonk, S., Kumar, S., Vijayan, M., Kandimalla, R., Kuruva, C. S., & Reddy, A. P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.067 · Cited by 119 · see citing works
Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer
Devkar, T. B., Tekade, A. R., & Khandelwal, K. R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.06.037 · Cited by 118 · see citing works
Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumors
Sawyer, A. J., Saucier-Sawyer, J. K., Booth, C. J., Liu, J., Patel, T., Piepmeier, J. M., & Saltzman, W. M. (2010) · Drug Delivery and Translational Research · doi:10.1007/s13346-010-0001-3 · Cited by 118 · see citing works
Surface properties, more than size, limiting convective distribution of virus-sized particles and viruses in the central nervous system
Chen, M. Y., Hoffer, A., Morrison, P. F., Hamilton, J. F., Hughes, J. A., Schlageter, K. S., Lee, J., Kelly, B. R., & Oldfield, E. H. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.103.2.0311 · Cited by 118 · see citing works
New methods for direct delivery of chemotherapy for treating brain tumors.
Sawyer, A. J., Piepmeier, J. M., & Saltzman, W. M. (2006) · PubMed Central · Cited by 116 · see citing works
Edaravone-Encapsulated Agonistic Micelles Rescue Ischemic Brain Tissue by Tuning Blood-Brain Barrier Permeability
Jin, Q., Cai, Y. C., Li, S., Liu, H., Zhou, X., Lu, C., Gao, X., Qian, J., Zhang, J., Ju, S., et al. (2017) · Theranostics · doi:10.7150/thno.18219 · Cited by 110 · see citing works
Focused Ultrasound Immunotherapy for Central Nervous System Pathologies: Challenges and Opportunities
Curley, C. T., Sheybani, N., Bullock, T. N. J., & Price, R. J. (2017) · Theranostics · doi:10.7150/thno.21225 · Cited by 109 · see citing works
A review on animal models of stroke: An update
Kumar, A., Aakriti, & Gupta, V. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.016 · Cited by 107 · see citing works
Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1
Bertrand, Y., Currie, J.-C., Poirier, J., Demeule, M., Abulrob, A., Fatehi, D., Stanimirovic, D. B., Sartelet, H., Castaigne, J., & Béliveau, R. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.427 · Cited by 100 · see citing works
Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles
Neeves, K. B., Sawyer, A. J., Foley, C. P., Saltzman, W. M., & Olbricht, W. L. (2007) · Brain Research · doi:10.1016/j.brainres.2007.08.050 · Cited by 99 · see citing works
Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting
Feng, Q., Shen, Y., Fu, Y., Muroski, M. E., Zhang, P., Wang, Q., Xu, C., Lesniak, M. S., Li, G., & Cheng, Y. (2017) · Theranostics · doi:10.7150/thno.18985 · Cited by 99 · see citing works
Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats
Khan, Z. A., & Bagad, M. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s80706 · Cited by 98 · see citing works
The Ligand Nanoparticle Conjugation Approach for Targeted Cancer Therapy
Karra, N., & Benita, S. (2011) · Current Drug Metabolism · doi:10.2174/138920012798356899 · Cited by 97 · see citing works
Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption
Foley, C. P., Rubin, D. G., Santillán, A., Sondhi, D., Dyke, J. P., Gobin, Y. P., Crystal, R. G., & Ballon, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.018 · Cited by 96 · see citing works
MiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery
Oller‐Salvia, B., Sánchez‐Navarro, M., Ciudad, S., Guiu, M., Arranz‐Gibert, P., Garcia, C., Gomis, R. R., Cecchelli, R., García, J., Giralt, E., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508445 · Cited by 92 · see citing works
Enhanced chemotherapy delivery by intraarterial infusion and blood‐brain barrier disruption in the treatment of cerebral metastasis
Fortin, D., Gendron, C., Boudrias, M., & Lapointe‐Garant, M. (2007) · Cancer · doi:10.1002/cncr.22450 · Cited by 91 · see citing works
Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease
Bartels, A. L. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440122 · Cited by 91 · see citing works
Updates in the medical management of Parkinson disease
Fernandez, H. H. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78gr.11005 · Cited by 90 · see citing works
Delivery of nanoparticles to the brain detected by fluorescence microscopy
Reimold, I., Domke, D., Bender, J., Seyfried, C. A., Radunz, H.-E., & Fricker, G. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.007 · Cited by 89 · see citing works
SiO2 nanoparticles change colour preference and cause Parkinson's-like behaviour in zebrafish
Li, X., Лю, Б., Li, X.-L., Li, Y.-X., Sun, M., Chen, D.-Y., Zhao, X. J., & Feng, X. (2014) · Scientific Reports · doi:10.1038/srep03810 · Cited by 88 · see citing works
Trafficking of Gold Nanoparticles Coated with the 8D3 Anti-Transferrin Receptor Antibody at the Mouse Blood–Brain Barrier
Cabezón, I., Manich, G., Martín-Venegas, R., Camins, A., Pelegrı́, C., & Vilaplana, J. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00597 · Cited by 88 · see citing works
Influence of Short-Chain Cell-Penetrating Peptides on Transport of Doxorubicin Encapsulating Receptor-Targeted Liposomes Across Brain Endothelial Barrier
Sharma, G., Modgil, A., Zhong, T., Sun, C., & Singh, J. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1242-x · Cited by 87 · see citing works
Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat Model
Jiang, W., Xie, H., Ghoorah, D., Shang, Y., Shi, H., Liu, F., Yang, X., & Xu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037376 · Cited by 86 · see citing works
Self-Assembled Polymersomes Conjugated with Lactoferrin as Novel Drug Carrier for Brain Delivery
Yu, Y., Pang, Z., Lü, W., Yin, Q., Gao, H., & Jiang, X. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0513-7 · Cited by 86 · see citing works
Enhanced Glioma Targeting and Penetration by Dual-Targeting Liposome Co-modified with T7 and TAT
Zong, T., Mei, L., Gao, H., Shi, K., Chen, J., Wang, Y., Zhang, Q., Yang, Y., & He, Q. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24186 · Cited by 86 · see citing works
Smart Nanodevice Combined Tumor-Specific Vector with Cellular Microenvironment-Triggered Property for Highly Effective Antiglioma Therapy
Shao, K., Ding, N., Huang, S., Ren, S., Zhang, Y. X., Kuang, Y., Guo, Y., Ma, H., An, S., Li, Y., et al. (2014) · ACS Nano · doi:10.1021/nn406285x · Cited by 86 · see citing works
Folic Acid-Conjugated MnO Nanoparticles as a T 1 Contrast Agent for Magnetic Resonance Imaging of Tiny Brain Gliomas
Chen, N., Shao, C., Qu, Y., Li, S., Gu, W., Zheng, T., Ye, L., & Yu, C. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am505223t · Cited by 81 · see citing works
Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis
Wang, B., Lv, L., Wang, Z., Zhao, Y., Wu, L. H., Fang, X., Xu, Q., & Xin, H. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.068 · Cited by 78 · see citing works
Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice
Serralheiro, A., Alves, G., Fortuna, A. C., & Falcão, A. C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.05.021 · Cited by 77 · see citing works
Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression
Jangula, A., & Murphy, E. J. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.058 · Cited by 76 · see citing works
Nanotechnology for the Detection and Therapy of Stroke
Kyle, S., & Saha, S. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400009 · Cited by 74 · see citing works
Nanotherapeutic systems for local treatment of brain tumors
Chakroun, R. W., Zhang, P., Lin, R., Schiapparelli, P. V., Quiñones‐Hinojosa, A., & Cui, H. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1479 · Cited by 73 · see citing works
Nanoparticle Enabled Drug Delivery Across the Blood Brain Barrier: in vivo and in vitro Models, Opportunities and Challenges
Gidwani, M., & Singh, A. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140508122558 · Cited by 72 · see citing works
Targeted Delivery of Proteins into the Central Nervous System Mediated by Rabies Virus Glycoprotein-Derived Peptide
Fu, A., Wang, Y., Zhan, L., & Zhou, R. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0667-y · Cited by 71 · see citing works
Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo
Huang, R., Ke, W., Han, L., Liu, Y., Shao, K., Jiang, C., & Pei, Y. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.12.008 · Cited by 69 · see citing works
Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood–Brain Barrier in a Rat Model of Parkinson's Disease
Kang, Y., Jung, H., Oh, J., & Song, D. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12580 · Cited by 68 · see citing works
The DrrAB Efflux System of Streptomyces peucetius Is a Multidrug Transporter of Broad Substrate Specificity
Li, W., Sharma, M., & Kaur, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.536136 · Cited by 64 · see citing works
Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer
Wu, T., & Zhou, S. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.10083 · Cited by 64 · see citing works
Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood–brain barrier
Sun, Z., Worden, M., Wroczynskyj, Y., Yathindranath, V., van Lierop, J., Hegmann, T., & Miller, D. W. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s62260 · Cited by 63 · see citing works
Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions
Kanthamneni, N., Sharma, S., Meenach, S. A., Billet, B., Zhao, J., Bachelder, E. M., & Ainslie, K. M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.043 · Cited by 63 · see citing works
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel
Wang, B., Lv, L., Wang, Z., Jiang, Y., Lv, W., Liu, X., Wang, Z., Zhao, Y., Xin, H., & Xu, Q. (2015) · Scientific Reports · doi:10.1038/srep16589 · Cited by 63 · see citing works
Transferrin and cell-penetrating peptide dual-functioned liposome for targeted drug delivery to glioma.
Zheng, C.-Y., Ma, C., Bai, E., Yang, K., & Xu, R. (2015) · PubMed Central · Cited by 60 · see citing works
Polymersomes conjugated to 83-14 monoclonal antibodies: Invitro targeting of brain capillary endothelial cells
Dieu, L., Wu, D., Palivan, C. G., Balasubramanian, V., & Huwyler, J. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.05.021 · Cited by 59 · see citing works
Role of scavenger receptors in peptide-based delivery of plasmid DNA across a blood–brain barrier model
Srimanee, A., Regberg, J., Hällbrink, M., Vajragupta, O., & Langel, Ü. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.014 · Cited by 59 · see citing works
Monocyte Trafficking, Engraftment, and Delivery of Nanoparticles and an Exogenous Gene into the Acutely Inflamed Brain Tissue – Evaluations on Monocyte-Based Delivery System for the Central Nervous System
Tong, H.-I., Kang, W., Davy, P. M. C., Shi, Y., Sun, S., Allsopp, R., & Lu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154022 · Cited by 59 · see citing works
Convection-Enhanced Delivery of a Virus-Like Nanotherapeutic Agent with Dual-Modal Imaging for Besiegement and Eradication of Brain Tumors
Pang, H., Chen, P., Wei, K., Huang, C., Shiue, Y., Huang, C.-Y., & Yang, H. (2019) · Theranostics · doi:10.7150/thno.30977 · Cited by 59 · see citing works
A novel Trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells
Shen, Z., Wu, H., Yang, S., Ma, X., Li, Z., Tan, M., & Wu, A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.022 · Cited by 56 · see citing works
Self-citation
Mucoadhesive Amphiphilic Methacrylic Copolymer-Functionalized Poly(ε-caprolactone) Nanocapsules for Nose-to-Brain Delivery of Olanzapine
da Fonseca, F. N., Betti, A. H., Carvalho, F. C., Gremião, M. P. D., Dimer, F. A., Guterres, S. S., Tebaldi, M. L., Rates, S. M. K., & Pohlmann, A. R. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2015.2078 · Cited by 56 · see citing works
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles
Vilella, A., Ruozi, B., Belletti, D., Pederzoli, F., Galliani, M., Semeghini, V., Forni, F., Zoli, M., Vandelli, M. A., & Tosi, G. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7020074 · Cited by 55 · see citing works
From venoms to BBB shuttles: Synthesis and blood–brain barrier transport assessment of apamin and a nontoxic analog
Oller‐Salvia, B., Teixidò, M., & Giralt, E. (2013) · Biopolymers · doi:10.1002/bip.22257 · Cited by 55 · see citing works
Biology of brain metastases and novel targeted therapies: Time to translate the research
Fokas, E., Steinbach, J., & Rödel, C. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.005 · Cited by 55 · see citing works
Developmental origins of brain tumors
Liu, C., & Zong, H. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.04.012 · Cited by 55 · see citing works
Increasing the oscillation frequency of strong magnetic fields above 101 kHz significantly raises peripheral nerve excitation thresholds
Weinberg, I. N., Stepanov, P. Y., Fricke, S. T., Probst, R., Urdaneta, M., Warnow, D. M., Sanders, H. D., Glidden, S. C., McMillan, A. B., Starewicz, P. M., et al. (2012) · Medical Physics · doi:10.1118/1.3702775 · Cited by 55 · see citing works
Local Delivery of Poly Lactic-co-glycolic Acid Microspheres Containing Imatinib Mesylate Inhibits Intracranial Xenograft Glioma Growth
Benny, O., Menon, L. G., Ariel, G., Goren, E., Kim, S., Stewman, C., Black, P. M., Carroll, R. S., & Machluf, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1316 · Cited by 53 · see citing works
Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound
Alkins, R. D., Brodersen, P. M., Sodhi, R. N. S., & Hynynen, K. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not052 · Cited by 53 · see citing works
Functionalized Nanoscale Micelles with Brain Targeting Ability and Intercellular Microenvironment Biosensitivity for Anti‐Intracranial Infection Applications
Shao, K., Zhang, Y. X., Ding, N., Huang, S., Wu, J., Li, J., Yang, C., Leng, Q., Ye, L., Lou, J., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400214 · Cited by 50 · see citing works
Considerations for the Development and Practice of Cascade Impaction Testing, Including a Mass Balance Failure Investigation Tree
Christopher, D., Curry, P., Doub, B., Furnkranz, K., Lavery, M., Lin, K. K., Lyapustina, S., Mitchell, J. P., Rogers, B., Strickland, H., et al. (2003) · Journal of Aerosol Medicine · doi:10.1089/089426803769017604 · Cited by 50 · see citing works
Blood-brain barrier disruption in humans using an implantable ultrasound device: quantification with MR images and correlation with local acoustic pressure
Asquier, N., Bouchoux, G., Canney, M. S., Martin, C., Law-Ye, B., Leclercq, D., Chapelon, J., Lafon, C., Idbaïh, A., & Carpentier, A. C. (2019) · Journal of neurosurgery · doi:10.3171/2018.9.jns182001 · Cited by 50 · see citing works
Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy
Zhan, C., Li, C., Wei, X., Lu, W., & Lu, W. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.025 · Cited by 49 · see citing works
A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer’s Disease: Establishment by Using Acitretin as a Model Drug
Freese, C., Reinhardt, S., Hefner, G., Unger, R. E., Kirkpatrick, C. J., & Endres, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091003 · Cited by 49 · see citing works
Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery
Chen, Y., Zhang, M., Jin, H., Li, D., Xu, F., Wu, A., Wang, J., & Huang, Y. (2017) · Theranostics · doi:10.7150/thno.20578 · Cited by 49 · see citing works
Receptor-Targeted Glial Brain Tumor Therapies
Sharma, P., & Debinski, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113326 · Cited by 49 · see citing works
Local Delivery of Brain-Derived Neurotrophic Factor Enables Behavioral Recovery and Tissue Repair in Stroke-Injured Rats
Obermeyer, J. M., Tuladhar, A., Payne, S. L., Ho, E., Morshead, C. M., & Shoichet, M. S. (2019) · Tissue Engineering Part A · doi:10.1089/ten.tea.2018.0215 · Cited by 49 · see citing works
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis
Lee, D.-H., Rötger, C., Appeldoorn, C. C. M., Reijerkerk, A., Gladdines, W., Gaillard, P. J., & Linker, R. A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.025 · Cited by 48 · see citing works
Transporter-Based Delivery of Anticancer Drugs to the Brain: Improving Brain Penetration by Minimizing Drug Efflux at the Blood-Brain Barrier
On, N. H., & Miller, D. W. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990458 · Cited by 47 · see citing works
Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial Tumors
Young, J. S., Bernal, G. M., Polster, S. P., Núñez, L., Larsen, G. F., Mansour, N. M., Podell, M., & Yamini, B. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.06.114 · Cited by 47 · see citing works
Quantitative analysis of the brain-targeted delivery of drugs and model compounds using nano-delivery systems
Kozlovskaya, L., & Stepensky, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.028 · Cited by 45 · see citing works
Uptake and transcytosis of functionalized superparamagnetic iron oxide nanoparticles in an in vitro blood brain barrier model
Ivask, A., Pilkington, E. H., Blin, T., Käkinen, A., Vija, H., Visnapuu, M., Quinn, J. F., Whittaker, M. R., Qiao, R., Davis, T. P., et al. (2017) · Biomaterials Science · doi:10.1039/c7bm01012e · Cited by 45 · see citing works

Flagged first, then by citations

2 of the 236 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

[78]Feng Q, Shen Y, Fu Y, Muroski ME, Zhang P, Wang Q, Xu C, Lesniak MS, Li G, Cheng Y, Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting. Theranostics 7 (2017) 1875– 1889. 28638474 PMC5479275

Sorted by citations

The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906 · see citing works
Self-citation
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138 · see citing works
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Narayanan, J., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,116 · see citing works
Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
Montoto, S. S., Muraca, G., & Ruiz, M. E. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587997 · Cited by 672 · see citing works
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 604 · see citing works
Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies
Ding, S., Khan, A. I., Cai, X., Song, Y., Lyu, Z., Du, D., Dutta, P., & Lin, Y. (2020) · Materials Today · doi:10.1016/j.mattod.2020.02.001 · Cited by 448 · see citing works
Pathophysiology of Blood–Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery
Bernardo-Castro, S., Sousa, J. A., Brás, A., Cecília, C., Rodrigues, B., Almendra, L., Machado, C., Santo, G., da Silva, F. A. D. A., Ferreira, L., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.594672 · Cited by 383 · see citing works
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378 · see citing works
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
Agrawal, M., Saraf, S., Saraf, S., Dubey, S. K., Puri, A., Gupta, U. D., Kesharwani, P., Ravichandiran, V., Kumar, P., Naidu, V. G. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.044 · Cited by 299 · see citing works
Blood–Spinal Cord Barrier in Spinal Cord Injury: A Review
Jin, L., Li, J., Wang, K., Xia, W., Zhu, Z., Wang, C., Li, X., & Liu, H. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7413 · Cited by 287 · see citing works
Macrophage Membrane-Camouflaged Responsive Polymer Nanogels Enable Magnetic Resonance Imaging-Guided Chemotherapy/Chemodynamic Therapy of Orthotopic Glioma
Xiao, T., He, M., Xu, F., Fan, Y., Jia, B., Shen, M., Wang, H., & Shi, X. (2021) · ACS Nano · doi:10.1021/acsnano.1c08689 · Cited by 231 · see citing works
Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1/M2 microglial polarization in an Alzheimer's disease model
Ren, C., Li, D., Zhou, Q., & Hu, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119752 · Cited by 228 · see citing works
Camouflaging Nanoparticles with Brain Metastatic Tumor Cell Membranes: A New Strategy to Traverse Blood–Brain Barrier for Imaging and Therapy of Brain Tumors
Wang, C., Wu, B., Wu, Y., Song, X., Zhang, S., & Liu, Z. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909369 · Cited by 217 · see citing works
Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
Choi, J., Kim, G., Cho, S. B., & Im, H. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00684-5 · Cited by 196 · see citing works
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
Gu, W., Meng, F., Haag, R., & Zhong, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.003 · Cited by 195 · see citing works
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
Mitusova, K. A., Peltek, O. O., Karpov, T. E., Muslimov, A. R., Zyuzin, M. V., & Timin, A. S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01610-7 · Cited by 186 · see citing works
Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics
Roy, S., Bag, N., Bardhan, S., Hasan, I., & Guo, B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114821 · Cited by 183 · see citing works
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Moradi, S. Z., Momtaz, S., Bayrami, Z., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00238 · Cited by 181 · see citing works
Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases
Masoudi Asil, S., Ahlawat, J., Guillama Barroso, G., & Narayan, M. (2020) · Biomaterials Science · doi:10.1039/d0bm00809e · Cited by 181 · see citing works
Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment
Zou, Y., Sun, Y., Wang, Y., Zhang, D., Yang, H., Wang, X., Zheng, M., & Shi, B. (2023) · Nature Communications · doi:10.1038/s41467-023-40280-3 · Cited by 189 · see citing works
An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy
Lu, L., Zhao, X., Fu, T., Li, K., He, Y., Luo, Z. Y., Dai, L., Zeng, R., & Cai, K. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119666 · Cited by 177 · see citing works
Nanotechnology-based drug delivery for central nervous system disorders
Nguyen, T. T., Nguyen, T. T. D., Vo, T. K., An, T. N. M., Nguyen, M. K., Toi, V. V., & Vo, G. V. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112117 · Cited by 181 · see citing works
Targeting pyroptosis as a preventive and therapeutic approach for stroke
Long, J., Sun, Y., Liu, S., Yang, S., Chen, C., Zhang, Z., Chu, S., Yang, Y., Pei, G., Lin, M., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01440-y · Cited by 153 · see citing works
Neurobiological effects of gallic acid: current perspectives
Bhuia, M. S., Rahaman, M. M., Islam, T., Bappi, M. H., Sikder, M. I., Hossain, K. N., Akter, F., Prottay, A. A. S., Rokonuzzman, M., Gürer, E. S., et al. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00735-7 · Cited by 154 · see citing works
Intelligent Micro‐/Nanorobots for Cancer Theragnostic
Wang, J., Dong, Y., Ma, P., Wang, Y., Zhang, F., Cai, B., Chen, P., & Liu, B. (2022) · Advanced Materials · doi:10.1002/adma.202201051 · Cited by 140 · see citing works
Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases
Zhang, Y., Yang, H. N., Wei, D., Zhang, X., Wang, J., Wu, X., & Chang, J. K. (2021) · Exploration · doi:10.1002/exp.20210115 · Cited by 133 · see citing works
Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor
Liu, H., & Xu, P. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114619 · Cited by 132 · see citing works
Blood–brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders
Alajangi, H. K., Kaur, M., Sharma, A., Rana, S., Thakur, S., Chatterjee, M., Singla, N., Jaiswal, P. K., Singh, G., & Barnwal, R. P. (2022) · Molecular Brain · doi:10.1186/s13041-022-00937-4 · Cited by 130 · see citing works
Smart Nanomedicine to Enable Crossing Blood–Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma
Wang, H., Chao, Y., Zhao, H., Zhou, X., Zhang, F., Zhang, Z., Li, Z., Pan, J., Wang, J., Chen, Q., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c08120 · Cited by 118 · see citing works
Progress in cancer drug delivery based on AS1411 oriented nanomaterials
Tong, X., Ga, L., Ai, J., & Wang, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01240-z · Cited by 117 · see citing works
An update on actively targeted liposomes in advanced drug delivery to glioma
Mojarad-Jabali, S., Farshbaf, M., Walker, P. R., Hemmati, S., Fatahi, Y., Zakeri‐Milani, P., Sarfraz, M., & Valizadeh, H. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120645 · Cited by 115 · see citing works
Gut-Brain Axis: Role of Microbiome, Metabolomics, Hormones, and Stress in Mental Health Disorders
Verma, A., Inslicht, S. S., & Bhargava, A. (2024) · Cells · doi:10.3390/cells13171436 · Cited by 133 · see citing works
Development of curcumin-loaded zein nanoparticles for transport across the blood–brain barrier and inhibition of glioblastoma cell growth
Zhang, H., van Os, W. L., Tian, X., Zu, G., Ribovski, L., Bron, R., Bussmann, J., Kros, A., Liu, Y., & Zuhorn, I. S. (2021) · Biomaterials Science · doi:10.1039/d0bm01536a · Cited by 109 · see citing works
Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy
Zhang, Z., Xu, X., Du, J., Chen, X., Xue, Y., Zhang, J., Yang, X., Chen, X. S., Xie, J., & Ju, S. (2024) · Nature Communications · doi:10.1038/s41467-024-44963-3 · Cited by 107 · see citing works
Self-citation
How Nanoparticles Open the Paracellular Route of Biological Barriers: Mechanisms, Applications, and Prospects
Wu, J., Zhu, Z., Liu, W., Zhang, Y., Kang, Y., Liu, J., Hu, C., Wang, R., Zhang, M., Chen, L., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05317 · Cited by 109 · see citing works
Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration
Wang, J., Ni, Q., Wang, Y., Zhang, Y., He, H., Gao, D., Ma, X., & Liang, X. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.045 · Cited by 101 · see citing works
Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain
Wu, J. R., Hernández, Y. M., Miyasaki, K. F., & Kwon, E. J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114820 · Cited by 103 · see citing works
Focusing on mitochondria in the brain: from biology to therapeutics
Song, N., Mei, S., Wang, X.-X., Hu, G., & Lu, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00409-w · Cited by 102 · see citing works
Biosensors integrated 3D organoid/organ-on-a-chip system: A real-time biomechanical, biophysical, and biochemical monitoring and characterization
Liu, S., Kumari, S., He, H., Mishra, P., Singh, B. N., Singh, D., Liu, S., Srivastava, P., & Li, C. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115285 · Cited by 99 · see citing works
Role of pyroptosis in the pathogenesis of various neurological diseases
Oladapo, A., Jackson, T., Menolascino, J., & Periyasamy, P. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.02.001 · Cited by 96 · see citing works
Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood–Brain Barrier by Using Different Transport Mechanisms
Song, J., Lu, C. T., Leszek, J., & Zhang, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810118 · Cited by 95 · see citing works
Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma
Shen, Z., Liu, T., Yáng, Z., Zhou, Z., Tang, W., Fan, W., Liu, Y., Mu, J., Li, L., Bregadze, V. I., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119783 · Cited by 92 · see citing works
Self-citation
The application of exosomes and Exosome-nanoparticle in treating brain disorders
Salarpour, S., Barani, M., Pardakhty, A., Khatami, M., & Chauhan, N. P. S. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.118549 · Cited by 92 · see citing works
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Mallick, R., Basak, S., Chowdhury, P., Bhowmik, P., Das, R. K., Banerjee, A., Paul, S., Pathak, S., & Duttaroy, A. K. (2025) · Pharmaceuticals · doi:10.3390/ph18010104 · Cited by 94 · see citing works
Advances in drug delivery technology for the treatment of glioblastoma multiforme
Cha, G. D., Kang, T., Baik, S., Kim, D., Choi, S., Hyeon, T., & Kim, D.-H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.002 · Cited by 91 · see citing works
Neisseria meningitidis Opca Protein/MnO2 Hybrid Nanoparticles for Overcoming the Blood–Brain Barrier to Treat Glioblastoma
Dong, C., Huang, Q., Cheng, H. L., Zheng, D., Hong, S., Yan, Y. Q., Niu, M., Xu, J., & Zhang, X. (2022) · Advanced Materials · doi:10.1002/adma.202109213 · Cited by 89 · see citing works
Biodistribution, degradability and clearance of 2D materials for their biomedical applications
Fan, T., Yan, L., He, S., Hong, Q., Ai, F., He, S., Ji, T., Hu, X., Ha, E., Zhang, B., et al. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01070k · Cited by 90 · see citing works
Self-citation
The Relationship between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors
Dong, M., Wen, S., & Zhou, L. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s375559 · Cited by 90 · see citing works
Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review
Zhang, Y., Guo, P., Ma, Z., Lü, P., Kebebe, D., & Liu, Z. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01002-3 · Cited by 88 · see citing works
Nanomaterials toward the treatment of Alzheimer’s disease: Recent advances and future trends
Zeng, H., Qi, Y., Zhang, Z., Liu, C., Peng, W., & Zhang, Y. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.014 · Cited by 84 · see citing works
BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment
Chen, W., Yao, S., Wan, J., Tian, Y., Huang, L., Wang, S., Akter, F., Wu, Y., Yao, Y., & Zhang, X. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.029 · Cited by 81 · see citing works
PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study
Hoyos-Ceballos, G. P., Ruozi, B., Ottonelli, I., da Ros, F., Vandelli, M., Forni, F., Daini, E., Vilella, A., Zoli, M., Tosi, G., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010072 · Cited by 77 · see citing works
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
Costa, C. P., Barreiro, S., Moreira, J. N., Silva, R., Almeida, H., Lobo, J. M. S., & Silva, A. C. (2021) · Pharmaceuticals · doi:10.3390/ph14080711 · Cited by 82 · see citing works
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Luo, M., Lee, L. K. C., Peng, B., Choi, C. H. J., Tong, W. Y., & Voelcker, N. H. (2022) · Advanced Science · doi:10.1002/advs.202201740 · Cited by 81 · see citing works
Overcoming the Blood–Brain Barrier for Gene Therapy via Systemic Administration of GSH‐Responsive Silica Nanocapsules
Wang, Y., Wang, X., Xie, R., Burger, J. C., Tong, Y., & Gong, S. (2022) · Advanced Materials · doi:10.1002/adma.202208018 · Cited by 82 · see citing works
Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy
Wang, L., Shi, Y., Jiang, J., Li, C., Zhang, H., Zhang, X., Jiang, T., Wang, L., Wang, Y., & Feng, L. P. (2022) · Small · doi:10.1002/smll.202203678 · Cited by 81 · see citing works
An NIR-Driven Upconversion/C3N4/CoP Photocatalyst for Efficient Hydrogen Production by Inhibiting Electron–Hole Pair Recombination for Alzheimer’s Disease Therapy
Ge, K., Li, Z., Wang, A., Bai, Z., Zhang, X., Zheng, X., Liu, Z., & Gao, F. (2023) · ACS Nano · doi:10.1021/acsnano.2c08499 · Cited by 81 · see citing works
FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA
Geng, Y., Long, X., Zhang, Y., Wang, Y., You, G., Guo, W., Zhang, Y., Zhang, Y., Cheng, X., Yuan, Z., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04461-4 · Cited by 83 · see citing works
Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
Çiftçi, F., Özarslan, A. C., Kantarci, İ. C., Yelkenci, A., Tavukçuoğlu, Ö., & Ghorbanpour, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010121 · Cited by 79 · see citing works
Near-Infrared Radiation-Assisted Drug Delivery Nanoplatform to Realize Blood–Brain Barrier Crossing and Protection for Parkinsonian Therapy
Liu, Y., Hong, H., Xue, J., Luo, J., Liu, Q., Chen, X., Pan, Y., Zhou, J., Liu, Z., & Chen, T. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c12675 · Cited by 75 · see citing works
Self-citation
Anti-inflammatory potential of quercetin: From chemistry and mechanistic insight to nanoformulations
Aggarwal, D., Chaudhary, M., Mandotra, S. K., Tuli, H. S., Chauhan, R., Joshi, N. C., Kaur, D., Dufossé, L., & Chauhan, A. P. S. (2025) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2025.100217 · Cited by 76 · see citing works
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 76 · see citing works
Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases
Li, J., Wei, Y., Zhang, C., Bi, R., Qiu, Y., Li, Y., & Hu, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020621 · Cited by 85 · see citing works
Lipid nanoparticles for mRNA delivery in brain via systemic administration
Cao, D., Hou, X., Wang, C., Wang, S., Liu, Z., Tian, M., Guo, K., Li, H., Kang, D. D., Zhong, Y., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw0730 · Cited by 73 · see citing works
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
Pandey, N., Anastasiadis, P., Carney, C. P., Kanvinde, P. P., Woodworth, G. F., Winkles, J. A., & Kim, A. J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114415 · Cited by 72 · see citing works
Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment
Lu, X., Zhang, Y., Wang, L., Li, G., Gao, J., & Wang, Y. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1883158 · Cited by 68 · see citing works
Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer
Cai, X., Drummond, C. J., Zhai, J., & Tran, N. L. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202404234 · Cited by 72 · see citing works
Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma
Zhuang, D., Zhang, H., Hu, G., & Guo, B. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01479-6 · Cited by 66 · see citing works
Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer
Mojarad-Jabali, S., Mahdinloo, S., Farshbaf, M., Sarfraz, M., Fatahi, Y., Atyabi, F., & Valizadeh, H. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2083106 · Cited by 67 · see citing works
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Saha, P., Kathuria, H., & Pandey, M. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.021 · Cited by 65 · see citing works
Low intensity focused ultrasound: a new prospect for the treatment of Parkinson’s disease
Zhong, Y., Liao, J., Liu, X., Tian, H., Deng, L.-R., & Long, L. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2251145 · Cited by 64 · see citing works
Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation
Shao, X., Yan, C., Wang, C., Wang, C., Cao, Y. Q., Zhou, Y., Guan, P., Hu, X., Zhu, W., & Ding, S. (2022) · Nanoscale Advances · doi:10.1039/d2na00625a · Cited by 63 · see citing works
Damage mechanism and therapy progress of the blood-brain barrier after ischemic stroke
Gao, H., Chen, H., Cui, G.-Y., & Hu, J.-X. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01126-z · Cited by 65 · see citing works
Platelet-derived extracellular vesicles ameliorate intervertebral disc degeneration by alleviating mitochondrial dysfunction
Dai, Z., Xia, C., Zhao, T., Wang, H., Tian, H., Xu, O., Zhu, X., Zhang, J., & Chen, P. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100512 · Cited by 62 · see citing works
Recent advances of engineering cell membranes for nanomedicine delivery across the blood–brain barrier
Yuan, S., Hu, D., Gao, D., Butch, C. J., Wang, Y., Zheng, H., & Sheng, Z. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03572-y · Cited by 63 · see citing works
Engineered Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as New Generations of Blood–Brain Barrier Transmitters
Amiri, M., Jafari, S., Kurd, M., Mohamadpour, H., Khayati, M., Ghobadinezhad, F., Tavallaei, O., Derakhshankhah, H., Malvajerd, S. S., & Izadi, Z. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00540 · Cited by 61 · see citing works
Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma
Luo, H., Zhang, H., Mao, J., Cao, H., Tao, Y., Zhao, G., Zhang, Z., Zhang, N., Liu, Z., Zhang, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05753-9 · Cited by 61 · see citing works
Hemorrhagic Conversion of Acute Ischemic Stroke
Zubair, A. S., & Sheth, K. N. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01377-1 · Cited by 61 · see citing works
Target-driven supramolecular self-assembly for selective amyloid-β photooxygenation against Alzheimer's disease
Liu, Z., Ma, M., Yu, D., Ren, J., & Qu, X. (2020) · Chemical Science · doi:10.1039/d0sc04984k · Cited by 61 · see citing works
Micro/nanosystems for controllable drug delivery to the brain
Tian, M., Ma, Z., & Yang, G. (2023) · The Innovation · doi:10.1016/j.xinn.2023.100548 · Cited by 60 · see citing works
Biomarker-activated multifunctional lysosome-targeting chimeras mediated selective degradation of extracellular amyloid fibrils
Liu, Z.-Q., Deng, Q.-Q., Qin, G., Yang, J., Zhang, H., Ren, J.-S., & Qu, X.-G. (2023) · Chem · doi:10.1016/j.chempr.2023.06.003 · Cited by 54 · see citing works
Neutrophil-Biomimetic “Nanobuffer” for Remodeling the Microenvironment in the Infarct Core and Protecting Neurons in the Penumbra via Neutralization of Detrimental Factors to Treat Ischemic Stroke
Liu, S., Xu, J., Liu, Y., You, Y., Xie, L., Tong, S., Chen, Y., Liang, K., Zhou, S., Li, F., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c09020 · Cited by 58 · see citing works
Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds
Zhang, Y., He, J., Shen, L., Wang, T., Yang, J., Li, Y., Wang, Y., & Quan, D. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.039 · Cited by 59 · see citing works
Low-Intensity Focused Ultrasound Technique in Glioblastoma Multiforme Treatment
Mungur, R., Zheng, J.-S., Wang, B., Chen, X., Zhan, R., & Tong, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.903059 · Cited by 57 · see citing works
Self-citation
Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier
Khan, M. S., Mohapatra, S., Gupta, V., Ali, A., Naseef, P. P., Kuruniyan, M. S., Alshadidi, A. A. F., Alam, M. S., Mirza, M. A., & Iqbal, Z. (2023) · Membranes · doi:10.3390/membranes13030343 · Cited by 57 · see citing works
Magnetic Particle Imaging: From Tracer Design to Biomedical Applications in Vasculature Abnormality
Xie, X., Zhai, J., Zhou, X., Guo, Z., Lo, P., Zhu, G., Chan, K. W. Y., & Yang, M. (2023) · Advanced Materials · doi:10.1002/adma.202306450 · Cited by 57 · see citing works
Mitochondria in brain diseases: Bridging structural-mechanistic insights into precision-targeted therapies
Liao, J., He, W., Li, L., Wang, J., Gong, L., Zhang, Q., & Lin, Z. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100016 · Cited by 62 · see citing works
Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance
Rhaman, M. M., Islam, M. R., Akash, S., Mim, M., Noor alam, M., Nepovimova, E., Valis, M., Kuca, K., & Sharma, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.989471 · Cited by 63 · see citing works
Nanotechnology-based herbal medicine: Preparation, synthesis, and applications in food and medicine
Awlqadr, F. H., Majeed, K. R., Altemimi, A. B., Hassan, A. M. A., Qadir, S. A., Saeed, M. N., Faraj, A. M., Salih, T. H., Al‐Manhel, A. J. A., Najm, M. A. A., et al. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.101661 · Cited by 56 · see citing works
Patient‐derived xenograft models in pan‐cancer: From bench to clinic
Li, J., Gu, A., Tang, N., Zengin, G., Li, M., & Liu, Y. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20250016 · Cited by 62 · see citing works
Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis
Li, H., Ding, Y., Huang, J., Zhao, Y., Chen, W., Tang, Q., An, Y., Chen, R., & Hu, C. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s395246 · Cited by 55 · see citing works
Stroke-induced damage on the blood–brain barrier
Xue, S., Zhou, X., Yang, Z., Si, X., & Sun, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1248970 · Cited by 55 · see citing works
An Engineered Nanoplatform with Tropism Toward Irradiated Glioblastoma Augments Its Radioimmunotherapy Efficacy
Wang, Z., Chen, F., Cao, Y., Zhang, F., Sun, L., Yang, C., Xie, X., Wu, Z., Sun, M., Ma, F., et al. (2024) · Advanced Materials · doi:10.1002/adma.202314197 · Cited by 55 · see citing works
Biomimetic and cell-based nanocarriers – New strategies for brain tumor targeting
Mendanha, D., de Castro, J. V., Ferreira, H., & Neves, N. M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.047 · Cited by 55 · see citing works
Brain Delivery of Biomimetic Phosphorus Dendrimer/Antibody Nanocomplexes for Enhanced Glioma Immunotherapy via Immune Modulation of T Cells and Natural Killer Cells
Peng, Y., Zhan, M., Karpus, A. O., Zou, Y., Mignani, S. M., Majoral, J., Shi, X., & Shen, M. (2024) · ACS Nano · doi:10.1021/acsnano.3c13088 · Cited by 54 · see citing works
Drug delivery strategies with lipid-based nanoparticles for Alzheimer’s disease treatment
Jang, Y.-J., Kang, S.-J., Park, H. S., Lee, D., Kim, J. H., Kim, J.-E., Kim, D., Chung, C., Yoon, J., & Bhang, S. H. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03109-3 · Cited by 62 · see citing works
Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies
Pereira‐Silva, M., Jarak, I., Alvarez‐Lorenzo, C., Concheiro, Á., Paiva‐Santos, A. C., Veiga, F., & Figueiras, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.041 · Cited by 55 · see citing works
Promoting Reactive Oxygen Species Generation: A Key Strategy in Nanosensitizer-Mediated Radiotherapy
Jia, S., Ge, S., Fan, X., Leong, K. W., & Ruan, J. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0448 · Cited by 54 · see citing works
Macrophage–Cancer Hybrid Membrane-Camouflaged Nanoplatforms for HIF-1α Gene Silencing-Enhanced Sonodynamic Therapy of Glioblastoma
Li, Y., Liu, Y., Xu, J., Chen, D., Wu, T., & Cao, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c03001 · Cited by 53 · see citing works
Recent advances in the design of inorganic and nano-clay particles for the treatment of brain disorders
Persano, F., Batasheva, S., Fakhrullina, G., Gigli, G., Leporatti, S., & Fakhrullin, R. F. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02957b · Cited by 53 · see citing works

Advances in CNS drug delivery strategies to cross the blood-brain barrier
Li, G., Li, Z., Sun, Y., Bu, T., Chen, S., Yang, L., Li, Z., Mao, W., & Jia, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111524 · Cited by 8 · see citing works
Harnessing nanotechnology for improved drug delivery across the blood-brain barrier and enhanced neural repair
Xu, M., Wang, H., Wang, C., Wang, C., Hu, S., & Weng, L. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126221 · Cited by 2 · see citing works
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708 · see citing works
The Route of Nanomaterials Entering Brain
Liu, Y., & He, Q. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804598-5.00002-7 · Cited by 13 · see citing works
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review
Kulkarni, M., Patel, K., Patel, A. K., Patel, S., Desai, J. L., Patel, M. M., Shah, U., Patel, A. D., & Solanki, N. D. (2023) · ADMET & DMPK · doi:10.5599/admet.2043 · Cited by 38 · see citing works

Authors: Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X.
Affiliations: Innovation Center of NanoMedicine (JP)
National Institutes of Health (US)
Corresponding author: Shen, Zheyu
Kataoka, Kazunori
Chen, Xiaoyuan
ORCID: Xie, Jinbing
Shen, Zheyu
Anraku, Yasutaka
Kataoka, Kazunori
Chen, Xiaoyuan
Venue: Biomaterials
Publisher: Elsevier BV
Published: 2019-12
Volume: 224
Pages: 119491
ISSN: 0142-9612 (ISSN-L)
DOI: 10.1016/j.biomaterials.2019.119491
PMC: PMC6915305
OpenAlex: W2973160898
Cited by: 604
References: 236
Citations by year: 2026: 64 · 2025: 131 · 2024: 116 · 2023: 104 · 2022: 92 · 2021: 57 · 2020: 38 · 2019: 2
FWCI: 4.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Biomaterials (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: blood-brain barrier, BBB crossing, nanomaterials, brain drug delivery, central nervous system disorders, intranasal drug delivery, blood-brain barrier disruption, cell-penetrating peptides, receptor-mediated transcytosis, theranostic agents
MeSH terms: Animals, Blood-Brain Barrier, Central Nervous System Diseases, Clinical Trials as Topic, Disease Models, Animal, Humans, Drug Delivery Systems, Nanostructures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks